Skip to main content
Table of Contents
Print

What Neurotransmitters Are Targeted by ADHD Medications? 

Author: Avery Lombardi, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Understanding the neurotransmitters targeted by ADHD medication helps explain how these treatments improve focus, attention, and impulse control. Most ADHD medications work by increasing the availability of two key brain chemicals: dopamine and norepinephrine. 

Dopamine: The Motivation and Reward Messenger 

Dopamine is crucial for regulating motivation, reward processing, and attention. People with ADHD often have lower levels of dopamine in areas of the brain responsible for executive function. Stimulant medications like methylphenidate and amphetamine-based drugs increase dopamine by blocking its reuptake, allowing it to remain active in the brain for longer. This boost helps improve concentration, task initiation, and goal-directed behaviour. 

Norepinephrine: Supporting Alertness and Focus 

Norepinephrine helps control alertness, arousal, and the brain’s response to stress. It works alongside dopamine to enhance focus and manage emotional responses. ADHD medications either increase norepinephrine levels or improve how effectively it’s used by the brain. Non-stimulant medications, such as atomoxetine, primarily target norepinephrine by inhibiting its reuptake, improving attention and reducing impulsivity without stimulating dopamine as strongly. 

Balancing Both for Symptom Control 

Some medications influence both dopamine and norepinephrine, offering a more comprehensive effect on ADHD symptoms. The balance of these neurotransmitters is essential for managing the condition effectively, which is why different medication types are available to match individual neurochemical needs. 

In conclusion, neurotransmitters targeted by ADHD medications, helping restore balance in brain pathways related to attention, focus, and behaviour control. 

Visit providers like ADHD Certify for personal consultations and expert guidance tailored to your unique situation. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medications for ADHD.

Avery Lombardi, MSc
Author

Avery Lombardi is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Psychology. She has professional experience in psychological assessment, evidence-based therapy, and research, working with both child and adult populations. Avery has provided clinical services in hospital, educational, and community settings, delivering interventions such as CBT, DBT, and tailored treatment plans for conditions including anxiety, depression, and developmental disorders. She has also contributed to research on self-stigma, self-esteem, and medication adherence in psychotic patients, and has created educational content on ADHD, treatment options, and daily coping strategies.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories